Le Lézard
Classified in: Health
Subject: MAV

/R E P E A T -- Notice to the media - Minister of Health to speak at the 2017 Canadian Cardiovascular Conference/


VANCOUVER, Oct. 20, 2017 /CNW/ - The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will mark the one-year anniversary of the Healthy Eating Strategy by highlighting the progress that has been made to date during her keynote address at the 2017 Canadian Cardiovascular Conference.

Periscope channel for live stream of Minister's address: www.periscope.tv/HealthCanada

There will be a media availability following the Minister's remarks.

Media attending the event are required to register at the media registration office at the Thurlow St. entrance of the convention centre in order to receive an access badge.

Date
October 21, 2017

Time
Minister's Address: 9:00
Media Availability: 9:30

Location
Vancouver Convention Centre
West Building
Room 211
1055 Canada Place
Vancouver, BC 

 

SOURCE Health Canada


These press releases may also interest you

at 03:11
The eighth Aurora Prize for Awakening Humanity was awarded Thursday evening to Dr. Denis Mukwege, a world-renown gynecological surgeon and human rights activist from the Democratic Republic of the Congo (DRC). Dr. Mukwege is the president of Panzi...

at 03:05
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK's National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to...

at 03:00
Charging an electric vehicle (EV) at home is certainly more convenient than using a public charging station, but what are the other benefits? Along with convenience, the...

at 02:15
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...



News published on and distributed by: